Company profile for Veraxa Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VERAXA Biotech is a next-generation antibody therapeutics pioneer, leveraging breakthrough science from EMBL to develop transformative ADC and BiTAC TCE platforms. Our quality-by-design approach accelerates novel biologics from discovery to clinical development, targeting oncology and complex diseases with precision. By combining proprietary technologies with deep antibody expertise, we're building a diversified pipeline of be...
VERAXA Biotech is a next-generation antibody therapeutics pioneer, leveraging breakthrough science from EMBL to develop transformative ADC and BiTAC TCE platforms. Our quality-by-design approach accelerates novel biologics from discovery to clinical development, targeting oncology and complex diseases with precision. By combining proprietary technologies with deep antibody expertise, we're building a diversified pipeline of best-in-class therapies to address unmet medical needs globally.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Im Neuenheimer Feld 584 69120 Heidelberg
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/09/30/3158495/0/en/VERAXA-Biotech-and-Secarna-Pharmaceuticals-Initiate-Antibody-Oligonucleotide-Conjugate-Alliance-in-Immunology.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/07/17/3116951/0/en/VERAXA-Biotech-and-Voyager-Acquisition-Corp-Announce-Filing-of-Form-F-4-Registration-Statement-with-the-SEC.html

GLOBENEWSWIRE
17 Jul 2025

https://www.globenewswire.com/news-release/2025/05/29/3090517/0/en/VERAXA-Biotech-to-Attend-Key-Industry-Conferences-to-Showcase-BiTAC-Technology-Platform.html

GLOBENEWSWIRE
29 May 2025

https://www.globenewswire.com/news-release/2025/05/20/3084508/0/en/VERAXA-Biotech-Appoints-Rick-Austin-as-Chief-Scientific-Officer.html

GLOBENEWSWIRE
20 May 2025

https://www.globenewswire.com/news-release/2025/05/05/3073751/0/en/VERAXA-Biotech-Enters-Co-discovery-Alliance-with-OmniAb-for-a-Novel-Bispecific-Antibody-Drug-Conjugate-Program.html

GLOBENEWSWIRE
05 May 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/veraxa-biotech-merge-with-spac-voyager-164-billion-deal-2025-04-23/

REUTERS
23 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty